LifeMD, Inc. (LFMD)
NASDAQ: LFMD · Real-Time Price · USD
4.730
+0.010 (0.21%)
Jan 14, 2025, 4:00 PM EST - Market closed
LifeMD Market Cap
LifeMD has a market cap or net worth of $204.87 million as of January 14, 2025. Its market cap has decreased by -36.98% in one year.
Market Cap
204.87M
Enterprise Value
192.42M
1-Year Change
-36.98%
Ranking
Category
Stock Price
$4.73
Market Cap Chart
Since April 1, 2013, LifeMD's market cap has increased from $3.50M to $204.87M, an increase of 5,753.32%. That is a compound annual growth rate of 41.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 13, 2025 | 204.40M | -4.66% |
| Dec 31, 2024 | 214.40M | -31.89% |
| Dec 29, 2023 | 314.80M | 416.07% |
| Dec 30, 2022 | 61.00M | -48.48% |
| Dec 31, 2021 | 118.40M | -22.11% |
| Dec 31, 2020 | 152.00M | 2,391.80% |
| Dec 31, 2019 | 6.10M | -4.69% |
| Dec 31, 2018 | 6.40M | -57.62% |
| Dec 29, 2017 | 15.10M | 65.93% |
| Dec 30, 2016 | 9.10M | 145.95% |
| Dec 31, 2015 | 3.70M | 19.35% |
| Dec 31, 2014 | 3.10M | -59.21% |
| Dec 31, 2013 | 7.60M | 117.14% |
View and export this data all the way back to 2013.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 670.74B |
| UnitedHealth Group | 500.40B |
| Novo Nordisk | 362.64B |
| Johnson & Johnson | 348.50B |
| AbbVie | 310.22B |
| Merck & Co. | 252.08B |
| Thermo Fisher Scientific | 213.05B |
| AstraZeneca | 200.99B |